THE EVIDENCE IS OVERWHELMING CGM reduces time in hypoglycaemia by 27% and improves monitoring adherence by 33% (IDF/market meta-analysis, 2025) CGM reduces long-term risk of retinopathy, nephropathy, neuropathy, and cardiovascular events the complications that consume the vast majority of the $966B+ annual diabetes healthcare budget We are now at an inflection point in CGM technology
Taken together, evidence from neuroscience, human research, and clinical practice suggests meaningful overlap between obesity and addiction-related mechanisms. Leggio says that his lab has long been interested in how gut-brain neuroendocrine pathways may influence alcohol use disorder (AUD)
Supporting Healthy Hair Throughout Your Weight Loss Journey Hair thinning during GLP-1 treatment can be concerning, but for most people, its a temporary response to rapid weight loss rather than a permanent side effect
DerKoz Yorumu Nutraxin L-Carnitine, enerji art ve ya yakmn hzlandrma konusunda etkili bir destek salar